Energy drink company Celsius Holdings(NASDAQ: CELH) was the belle of the stock market ball in recent years. From the start of 2019 through the end of 2023, shares were up more than 4,600%, turning a $10,000 investment into more than $470,000. But in 2024, Celsius stock is down about 4%, and it's down 45% from this year's highs. This isn't just a case of stock market volatility. On the contrary, investors are digesting multiple headline issues that paint a bearish picture for the outlook of Celsius' business. For starters, investors are looking at sales data that shows slowing growth. Investors already know that growth for Celsius is slowing -- revenue in the first quarter of 2024 was only up 37% year over year, compared to 95% growth in the prior-year period. But investors and analysts who monitor sales trends for the industry believe growth is slowing even further, prompting some analyst to lower price targets for Celsius stock. There are also health-related concerns with Celsius making the rounds on social media. Many investors are starting to believe that there are health risks with energy drinks. They also think that people are becoming more aware of the risks and have consequently cut the products from their shopping routines. Many readers are likely too young to remember what was happening with the stock market in 2012. But some of us (ahem, me) are old enough to remember a very similar situation with Monster Beverage(NASDAQ: MNST). Here's what happened back then and how it could apply to Celsius' shareholders today. When Monster stock crashed hard In the decade leading up to 2012, Monster stock was one of the greatest investments of all time. I'm not exaggerating. If you had invested $10,000 in Monster stock at the start of 2002, you would have had $1.76 million at the start of 2012. In short, growth was extraordinary and investors were rewarded. But 2012 brought something different for Monster's shareholders. The headlines were chock-full of stories regarding the danger of sugar. As an example, New York City's then-mayor Michael Bloomberg proposed portion controls on sugary drinks that year -- it was a big deal. The headlines also bombarded investors with stories about the dangers of energy drinks, not unlike today with Celsius. Don't misunderstand: Sales for Monster did slow to a crawl as a result of these things. Many investors thought that this stock's magnificent run was over. As they moved on from their positions in Monster, shares fell 48% from its 2012 highs. MNST Chart The 2012 low for Monster stock came during the last week of October, and it was a great time to buy, even though bearish sentiment was reaching a fever pitch. Since then, Monster stock is up more than 600%, compared with just a 300% return for the S&P 500. What does this have to do with Celsius? Returns for Monster stock in 2012 and returns for Celsius stock in 2024 illustrate an important investing truth: Over short time periods, feelings can influence returns. As the news cycle turned bearish on both companies, both stocks fell. However, with Monster, the news cycle couldn't keep the stock down because the business results lifted it back up. Over the last 10 years, the company's revenue has tripled, and earnings per share (EPS) have nearly quadrupled. It's hard to keep a stock down when that's the case. For Celsius, the questions investors should ask are whether it's poised for more growth and whether it can do it profitably. If it can, then investors may have completely forgotten what they were worried about in 2024 by the time 2034 rolls around. One thing that Celsius has in its favor is a strong relationship with PepsiCo, one of the largest consumer-packaged goods companies in the world. Pepsi doesn't just help with distribution --it also has an equity stake. It's good to have a powerful ally in a competitive space. Another thing in Celsius' favor for the long term is its relatively small size. It's grown by leaps and bounds in recent years. But with annual revenues only recently crossing $1 billion, it still has plenty of upside potential. For perspective, Monster generates over $7 billion in annual revenue. The good thing here is that Celsius has focused on growth over optimal profitability. But now that growth has slowed, it can make some operational improvements to maximize higher profits. Therefore, there's a chance for higher revenues and profits. I'm not saying that there aren't any concerns ahead for Celsius. Investors will want to monitor sales and the public perception of its products. But more often than not, investors overreact in the short term, which creates great opportunities for those with a long-term mindset. Don’t miss this second chance at a potentially lucrative opportunity Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves: Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $21,739!* Apple: if you invested $1,000 when we doubled down in 2008, you’d have $44,371!* Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $353,948!* Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon. See 3 “Double Down” stocks » *Stock Advisor returns as of July 15, 2024 Jon Quast has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Celsius and Monster Beverage. The Motley Fool has a disclosure policy. Celsius Stock Has Plunged Nearly 50% From 2024 Highs. Here's What Happened to Monster Beverage Stock When the Same Thing Happened in 2012. was originally published by The Motley Fool
Celsius Stock Has Plunged Nearly 50% From 2024 Highs. Here's What Happened to Monster Beverage Stock When the Same Thing Happened in 2012.
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...